CIBC Bancorp USA’s Envoy Medical COCH Stock Holding History

CIBC Bancorp USA’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$61.7K	Hold	77,887	–	–	﹤0.01%	1888
2026 Q1	$51.8K	Buy	+77,887	New	+$53.1K	﹤0.01%	1716

Other funds holding COCH

NCM

Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DCA

DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ACP

Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

CIBC Bancorp USA's COCH Position: Q2 2026 in Review

CIBC Bancorp USA held its Envoy Medical (COCH) position steady in Q2 2026 at 77,887 shares worth $61.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1888.

CIBC Bancorp USA first reported a position in COCH in Q1 2026 and has held it in 2 quarters since. 33 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

CIBC Bancorp USA held 77,887 shares of Envoy Medical worth $61.7K as of Q2 2026.
CIBC Bancorp USA left its Envoy Medical share count unchanged in Q2 2026.
Envoy Medical made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1888 holding.
CIBC Bancorp USA first reported a position in Envoy Medical in Q1 2026 and has held it in 2 quarters since.
33 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.